Siyu Shi

Siyu Shi, MD, MBA, is a prominent figure in the biotech and healthcare sectors, currently engaged with Mountainfield Venture Partners in biotech company creation and serving as co-founder and Senior Director of Operations at Timberlyne Therapeutics. Prior experience includes roles in biotech venture capital at F-Prime Capital and research in AI applications for healthcare at the Stanford Artificial Intelligence Laboratory. Notably, Siyu Shi contributed to oncology research at Stanford Health Care, leading to multiple publications and presentations at international conferences. Previous engagements also include positions at Blackstone, C3 AI, and Sofinnova Partners, alongside research in biomaterials at the Massachusetts Institute of Technology. Siyu Shi holds an MD from Stanford University School of Medicine and an MBA from Stanford Graduate School of Business, complemented by a Master's in Epidemiology from Stanford and a Bachelor's in Chemistry from Rice University.